Literature DB >> 25858294

Functional brain changes underlying irritability in premanifest Huntington's disease.

Jan Van den Stock1,2, François-Laurent De Winter1,2, Rawaha Ahmad3,4, Stefan Sunaert3,5, Koen Van Laere3,4, Wim Vandenberghe6, Mathieu Vandenbulcke1,2.   

Abstract

The clinical phenotype of Huntington's disease (HD) consists of motor, cognitive and psychiatric symptoms, of which irritability is an important manifestation. Our aim was to identify the functional and structural brain changes that underlie irritability in premanifest HD (preHD). Twenty preHD carriers and 20 gene-negative controls from HD families took part in the study. Although the 5-year probability of disease onset was only 11%, the preHD group showed striatal atrophy and increased clinical irritability ratings. Functional MRI was performed during a mood induction experiment by means of recollection of emotional (angry, sad, and happy) and neutral autobiographical episodes. While there were no significant group differences in the subjective intensity of the emotional experience, the preHD group showed increased anger-selective activation in a distributed network, including the pulvinar, cingulate cortex, and somatosensory association cortex, compared to gene-negative controls. Pulvinar activation during anger experience correlated negatively with putaminal grey matter volume and positively with irritability ratings in the preHD group. In addition, the preHD group showed a decrease in anger-selective activation in the amygdala, which correlated with putaminal and caudate grey matter volume. In conclusion, compared to gene-negative controls, anger experience in preHD is associated with activity changes in a distributed set of regions known to be involved in emotion regulation. Increased activity is related to behavioral and volumetric measures, providing insight in the pathophysiology of early neuropsychiatric symptoms in preHD.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  affective symptoms; aggression; amygdala; emotions; gyrus cingulus; pulvinar

Mesh:

Year:  2015        PMID: 25858294      PMCID: PMC6869704          DOI: 10.1002/hbm.22799

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  41 in total

1.  Neural correlates of levels of emotional awareness. Evidence of an interaction between emotion and attention in the anterior cingulate cortex.

Authors:  R D Lane; E M Reiman; B Axelrod; L S Yun; A Holmes; G E Schwartz
Journal:  J Cogn Neurosci       Date:  1998-07       Impact factor: 3.225

2.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

Review 3.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

4.  Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.

Authors:  Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2010-12-01       Impact factor: 18.112

5.  Irritability in pre-clinical Huntington's disease.

Authors:  Stefan Klöppel; Cynthia M Stonnington; Predrag Petrovic; Dean Mobbs; Oliver Tüscher; David Craufurd; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Neuropsychologia       Date:  2009-10-28       Impact factor: 3.139

6.  Thalamic metabolism and symptom onset in preclinical Huntington's disease.

Authors:  A Feigin; C Tang; Y Ma; P Mattis; D Zgaljardic; M Guttman; J S Paulsen; V Dhawan; D Eidelberg
Journal:  Brain       Date:  2007-09-24       Impact factor: 13.501

7.  Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks.

Authors:  Darin D Dougherty; Scott L Rauch; Thilo Deckersbach; Carl Marci; Rebecca Loh; Lisa M Shin; Nathaniel M Alpert; Alan J Fischman; Maurizio Fava
Journal:  Arch Gen Psychiatry       Date:  2004-08

8.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

Review 9.  Huntington disease models and human neuropathology: similarities and differences.

Authors:  Jean Paul G Vonsattel
Journal:  Acta Neuropathol       Date:  2007-11-03       Impact factor: 17.088

10.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

View more
  11 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

Review 2.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

3.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

4.  Structural brain correlates of irritability and aggression in early manifest Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

5.  Dynamic Changes in Amygdala Psychophysiological Connectivity Reveal Distinct Neural Networks for Facial Expressions of Basic Emotions.

Authors:  Matteo Diano; Marco Tamietto; Alessia Celeghin; Lawrence Weiskrantz; Mona-Karina Tatu; Arianna Bagnis; Sergio Duca; Giuliano Geminiani; Franco Cauda; Tommaso Costa
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

6.  Theory of Mind Is Impaired in Mild to Moderate Huntington's Disease Independently from Global Cognitive Functioning.

Authors:  Giovanna Lagravinese; Laura Avanzino; Alessia Raffo De Ferrari; Roberta Marchese; Carlo Serrati; Paola Mandich; Giovanni Abbruzzese; Elisa Pelosin
Journal:  Front Psychol       Date:  2017-01-26

Review 7.  Amygdala Response to Emotional Stimuli without Awareness: Facts and Interpretations.

Authors:  Matteo Diano; Alessia Celeghin; Arianna Bagnis; Marco Tamietto
Journal:  Front Psychol       Date:  2017-01-10

8.  Gray Matter Volume of a Region in the Thalamic Pulvinar Is Specifically Associated with Novelty Seeking.

Authors:  Daphne Stam; Yun-An Huang; Jan Van den Stock
Journal:  Front Psychol       Date:  2018-02-27

Review 9.  Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.

Authors:  Julia Kaye; Terry Reisine; Steve Finkbeiner
Journal:  Fac Rev       Date:  2021-10-21

10.  Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington's disease.

Authors:  Qiang Li; Gang Li; Dan Wu; Hanbing Lu; Zhipeng Hou; Christopher A Ross; Yihong Yang; Jiangyang Zhang; Wenzhen Duan
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.